Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor
José L Sandoval1, S Intidhar Labidi-Galy2,3
1Department of Oncology, Hopitaux Universitaires de Geneve, Geneva, Switzerland.
Oncogene
|November 9, 2023
Abstract
No abstract available in PubMed .


